Proficio Capital Partners LLC Ionis Pharmaceuticals Inc Transaction History

Proficio Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$33.58 - $41.2 $412,866 - $506,554	12,295 New	12,295 $439,000
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $9,272 - $11,327	-157 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $2,607 - $3,617	42 Added 36.52%	157 $10,000
Q4 2018 Feb 08, 2019	BUY	$43.37 - $59.54 $1,864 - $2,560	43 Added 59.72%	115 $6,000
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $428 - $537	10 Added 16.13%	72 $4,000
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $1,378 - $1,723	34 Added 121.43%	62 $3,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $1,275 - $1,667	28	28 $1,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.46B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.